What Challenge Is Your Team Facing?

Whether you're evaluating AI tools, overcoming cryo-EM bottlenecks, tackling difficult targets, or improving predictive accuracy, the 2nd Structure-Based Drug Design Summit San Diego is designed around the real-world challenges discovery teams face every day.

Select your challenge below and find the sessions designed to help solve your challenge →

Distinguishing AI & ML tools from Hype

  • Hear from Calico Life Sciences on benchmarking AI/ML models against structural biology datasets and combining computational predictions with experimental validation to identify tools that genuinely improve SBDD outcomes.
  • Learn from iBio how generative AI can reengineer GPCRs into soluble formats for antibody discovery, alongside a dedicated panel featuring Pfizer, Calico Life Sciences, and iBio exploring where AI delivers genuine value across the discovery pipeline.
Calico
iBio
Pfizer at the Structure-Based Drug Design Summit San Diego

Predictive Modeling, Affinity Ranking & Experimental Validation

  • Explore predictive modeling strategies with LPJP Inc and Scripps Research during our dedicated technical workshop, covering docking, binding pose prediction, affinity estimation, free-energy calculations, and de novo protein design.
  • Discover how combining AI, physics-based modeling, and high-throughput screening can improve predictive performance and strengthen confidence in computationally designed molecules.

Cryo-EM Throughput, Automation & Microscope Access

  • Hear how Eli Lilly is scaling cryo-EM through automated workflows to reduce manual bottlenecks and accelerate structure-guided drug discovery.
  • Gain insights from Scripps Research on microfluidic sample preparation, multiplexed cryo-EM, and automated data processing, alongside Vilya Therapeutics on scaling automated X-ray crystallography and AI-driven structural biology workflows.
Eli_Lilly at the Structure-Based Drug Design Summit San Diego

Sample Preparation & Experimental Bottlenecks

  • Learn from Scripps Research how microfluidic sample preparation and multiplexed analysis can increase sample-processing capacity and accelerate structural characterization.
  • Join our interactive cryo-EM throughput panel featuring UC Irvine, Deep Apple Therapeutics, Scripps Research, and Eli Lilly to explore grid development, alternative sample preparation approaches, sample-specific behaviour, and strategies to reduce failed experiments.
Deep Apple Therapeutics
Eli_Lilly at the Structure-Based Drug Design Summit San Diego

Multi-Modal Data Integration & Breaking Down Data Silos

  • Explore how Vividion Therapeutics is integrating complementary structural and experimental insights to better understand protein-ligand interactions and improve confidence in drug discovery decisions.
  • Discover how our dedicated technical workshop brings together cryo-EM, X-ray crystallography, HDX, SAXS, and biochemical data to reconcile conflicting observations, break down data silos, and generate more actionable insights.
Vividion Therapeutics

Hard-to-Drug Targets & Emerging Modalities

  • Hear from Neomorph on the structure-based discovery of NEO-811, a first-in-class molecular glue degrader of ARNT, and Degron Therapeutics on leveraging cryo-EM to elucidate molecular glue-induced ternary complex formation.
  • Learn from UC Irvine how cryo-EM and cryo-tomography can generate structural insights into complex biological systems, alongside Foghorn Therapeutics and C4 Therapeutics on applying structural biology to targeted protein degradation and expanding the reach of SBDD beyond conventional small molecules.
C4 Therapeutics Inc
Degron Therapeutics
Foghorn Therapeutics
Neomorph